Katherine J. Turner
Nessuna posizione attualmente
Profilo
Katherine J.
Turner was Vice President of Research & Development for NUCRYST Pharmaceuticals Corp.
from June 2007 to April 30, 2008.
She joined NUCRYST Pharmaceuticals as Vice President of Research in June 2006.
Prior to NUCRYST, Dr. Turner served as Vice President of Validation Biology for Biogen Idec, Inc. from July 2001 to November 2005.
She was Vice President of Immunology and Hemostasis for Genetics Institute and Wyeth Pharmaceuticals.
She received a BS from the University of Sussex, UK and an MS and a PhD in Biochemistry from Virginia Polytechnic Institute & State University.
She completed post-doctoral research at Brandeis University and London University.
Precedenti posizioni note di Katherine J. Turner
Società | Posizione | Fine |
---|---|---|
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Direttore Tecnico/Scientifico/R&S | 30/04/2008 |
BIOGEN INC. | Corporate Officer/Principal | 01/11/2005 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Katherine J. Turner
University of Sussex | Undergraduate Degree |
Virginia Polytechnic Institute & State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOGEN INC. | Health Technology |
Aziende private | 3 |
---|---|
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
- Borsa valori
- Insiders
- Katherine J. Turner